Loading...
Loading...
Among the 7 tracked institutional investors we monitor, RIGL (RIGEL PHARMACEUTICALS INC) is held with a combined value of $145.63M across 4,779,476 shares. The largest holder is BlackRock, Inc. with a position worth $47.83M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$145.63M
Total Shares Held
4,779,476
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $47.83M | 0.00% | +6.3% |
| 2 | VANGUARD GROUP INC | $44.48M | 0.00% | New |
| 3 | STATE STREET CORP | $30.29M | 0.00% | +2.7% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $9.15M | 0.01% | -37.2% |
| 5 | MILLENNIUM MANAGEMENT LLC | $7.15M | 0.00% | -38.7% |
| 6 | CITADEL ADVISORS LLC | $4.57M | 0.00% | -30.2% |
| 7 | FMR LLC | $2.16M | 0.00% | +17.9% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of RIGL with a position worth $47.83M, representing 0.00% of their portfolio. In total, 7 institutional investors hold RIGL with a combined value of $145.63M.
In the most recent quarter, 1 fund opened a new position in RIGL. Additionally, 3 increased their holdings and 3 reduced their positions.
Institutional investors hold $145.63M worth of RIGL stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $47.83M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For RIGL, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their RIGL positions.